(December 21, 2015, 12:10 PM EST) -- HOUSTON — A Texas federal judge on Dec. 10 granted partial summary judgment to Solvay Pharmaceuticals Inc. (SPI) in a False Claims Act (FCA)/Anti-Kickback whistle-blower complaint alleging improper promotion of the blood pressure drug Aceon and the antidepressant drug Luvox (United States of America, ex rel. John King, et al. v. Solvay S.A., et al., No. 06-2662, S.D. Texas, Houston Div.; 2015 U.S. Dist. LEXIS 165792).
(Solvay opinion and order available. Document #28-151217-013Z.)
In 2006, John King and Tammy Drummond filed a whistle-blower complaint on behalf...
Solvay Gets Partial Summary Judgment In False Claims, Kickbacks Case
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login